BSF Enterprise Plc accelerates commercialisation prospects with ground-breaking collaboration
Lab-Grown Leather Ltd is transitioning its lab-grown leather technology from lab-scale to future products in a major step towards commercialization.
BSF Enterprise updates on Lab-Grown Leather, bio tissues advances and strategic developments
Discover how BSF Enterprise Plc is pioneering cell-based solutions, with a focus on lab-grown leather, biotech innovations, and veterinary breakthroughs.
Green Economy Mark Stocks – Latest News
The Green Economy Mark identifies companies with significant revenue from products and services that contribute to the green economy. This article delves into the latest updates from prominent Green Economy Mark stocks like CyanConnode Holdings, SAE Renewables, and Ilika. These companies are setting industry standards in sustainable energy, advanced battery technologies, and IoT communications, furthering […]
BSF Enterprise MD Che Connon assesses its unique Lab-Grown Leather (Q&A interview)
Discover how BSF Enterprise’s Lab-Grown Leather is revolutionizing the traditional leather industry with its sustainable, high-quality alternatives.
BSF Enterprise: Biotech innovations and Sustainable solutions (LON:BSFA)
Discover BSF Enterprise’s innovative approach to sustainable agriculture and tissue engineering. Learn how they harness cutting-edge technology for sustainability.
BSF Enterprise: Pioneering Sustainable Biotech with Lab-Grown Solutions and Strategic Innovation (VIDEO)
Discover how BSF Enterprise plc pioneers biotech innovation in fashion and meat production with lab-grown tissues and sustainable solutions.
BSF Enterprise making strong progress across portfolio of companies
BSF Enterprise PLC (LON:BSFA), the parent to a portfolio of innovative subsidiary companies developing cell-based tissue engineering solutions to deliver sustainable outcomes across a variety of sectors, has provided the following portfolio update. ● Lab Grown Leather (LGL): Revolutionising the leather industry with the world’s first and only scaffold-free lab-grown leather, 3D Bio Tissues (3DBT), on behalf […]
BSF Enterprise Plc Poised for Breakthrough with a Strategic Focus on Growth Markets say Shard
BSF Enterprise Plc (LON:BSFA) is rapidly positioning itself as a leader in the biotech and tissue engineering space, with significant strides in cultivated meat, lab-grown leather, and medical innovations. Since May 2023, the company has undertaken transformative steps to restructure and refine its strategy, which promises to unlock immense potential across various sectors. Analyst Joshua […]
BSF Enterprise’s Kerato partners with University of Montreal for corneal damage treatment
BSF Enterprise plc (LON:BSFA), the Main Market listed biotech company and owner of corneal tissue replacement company Kerato Ltd, has announced that Kerato Ltd has entered into a Heads of Terms agreement and research partnership with the University of Montreal in Canada. BSF’s 100% owned Kerato is an independent company established to commercialise new innovations […]
BSF Enterprise’s 3DBT achieves another milestone in its City-mix™ technology
BSF Enterprise plc (LON: BSFA), (OTCQB: BSFAF), the Main Market listed biotech company and owner of pioneering UK-based tissue engineering company 3D Bio-Tissues Ltd (3DBT) and corneal tissue replacement company Kerato Ltd, has received over £90,000 to date in payments and funding for several proof-of-concept (PoC) agreements for the development of cultivated leather samples. In […]